Trial · NCT07913425
Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents
NCT07913425, Not applicable, Not yet recruiting, University of Haifa
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents. Trials, record NCT07913425. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07913425
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents
- NCT number
- NCT07913425
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- University of Haifa
- Conditions
- Self Injurious Behavior, Self Injurious Behavior Without Suicidal Intent
- Interventions
- Cutting Down Program - a three-month cognitive-behavioral psychotherapy focused on reducing self-injury urges and behaviors in adolescents
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Self injury behaviors | (1) Before the first treatment meeting (2) 2 months after the treatment starts (after the 2nd parent session), (3) 3 months after the treatment starts (towards the end of the treatment), (4) 3 months after the end of the treatment (follow up). | Deliberate Self-Harm Inventory (DSHI): A 6-item self-report assessing the frequency of different types of non-suicidal self-injury behaviors adapted for the last month. The items are rated from 1 (not at all) to 5 (5 times or more), with the request to enter the exact number of self harm behaviors if participant selected any option that is more than 1. The minimum sum score is 6, and the maximun depends on the exact number of self harm behaviors the participant reports, with higher number indicates higher fequency of non-suicidal self injurious behaviors. The scale will also be administered one time before the beginning of the treatment asking about the last 6 months, using only the 1-5 item rating (min sum score: 6, max sum score: 30). The version asking about the last month will be administered at four time points as described in the Time Frame. |
| Primary | Self injury thoughts | (1) Before the first treatment meeting (2) 2 months after the treatment starts (after the 2nd parent session), (3) 3 months after the treatment starts (towards the end of the treatment), (4) 3 months after the end of the treatment (follow up). | Alexian Brothers Urge to Self-Injure Scale (ABUSI). A 5-item self-report addressing frequency and intensity of urges to self-injure in the past week. Each item is rated from 1 (not at all) to 7 (almost all the time/strong intensity of urges). The minimal sum score is 5 and the maximal is 35, with higher scores indicating higher frequency and intensity of urges to self-injure. |
| Secondary | Suicidal thoughts and behaviors | (1) Before the first treatment meeting (2) 2 months after the treatment starts (after the 2nd parent session), (3) 3 months after the treatment starts (towards the end of the treatment), (4) 3 months after the end of the treatment (follow up). | Columbia Suicide Severity Rating Scale, Child Version (C-SSRS). A 7-item self-report assessing incidence and severity of suicidal thoughts and behaviors. The first six items, scored as 0 (no) or 1 (yes), ask about the last two weeks, and the seventh item is an open question asking about the number of suicidal behaviors in the last month. The scale's score is the highest item endorsed among the first six items. Minimum score is 0 and maximum score is 6, with higher score indicating greater severity of suicidal thoughts and behaviors. |
| Secondary | Depressive symptoms | (1) Before the first treatment meeting (2) 2 months after the treatment starts (after the 2nd parent session), (3) 3 months after the treatment starts (towards the end of the treatment), (4) 3 months after the end of the treatment (follow up). | Short Mood and Feelings Questionnaire (SMFQ); A 13-item self report assessing the the respondent's recent feelings and behaviors, focusing on depressive symptoms in the last two weeks. Each item is rated from 0 (untrue) to 2 (true). The sum score can range from 0 to 26, with higher score indicating more depressive symptoms. |
| Secondary | Emotion dysregulation | (1) Before the first treatment meeting (2) 2 months after the treatment starts (after the 2nd parent session), (3) 3 months after the treatment starts (towards the end of the treatment), (4) 3 months after the end of the treatment (follow up). | Difficulties in Emotion Regulation Scale (DERS) - short version. An 18-item self-report assessing difficulties in regulating emotional distress. Key dimensions include nonacceptance of emotions, and difficulties in goal-directed behavior, impulse control, emotion awareness and clarity, and in use of regulation strategies. Each item is rated from 1 (almost never) to 5 (almost always). The sum score can range from 18 to 90, with higher score indicating more emotion dysregulation. |
| Secondary | Parental emotion socialization | (1) Before the first treatment meeting (2) 2 months after the treatment starts (after the 2nd parent session), (3) 3 months after the treatment starts (towards the end of the treatment), (4) 3 months after the end of the treatment (follow up). | Coping with Children's Negative Emotions Scale, measured in two versions: a. Adolescents' Perceptions of Parent (CCNES-APP). b. CCNES-A parent's perception. Each version includes the same nine scenarios depicting adolescents' emotional distress, for which respondents select the parent's responses. Responses range from validating, expressive encouragement, emotion- focus reactions and problem-focus reactions, to distress , minimizing or punitive reactions. There are seven possible parental responses to each of the 9 scenarios, with each response rated from 1 (very unlikely) to 7 (very likely). The final score is divided into two average scores: supportive responses and unsupportive responses. Each score can range from 1 to 7, with higher score indicating greater likelihood that parents use this type of responses. Parents and adolescent versions will be computed separately to create distinct informant scores on parental emotion socialization. |
| Other | Sociodemographic information for descriptive purposes | Before the first treatment meeting. | Data will be collected from parents questionnaire on demographics, household composition, place of birth, parental involvement, parental socioeconomic status and religiosity using questions derived from the Global School-Based Pupil Health Survey (GSHS). The only ordinal items ask about socioeconomic status (min - 1, max - 5, with higher score indicating lower SES), degree of parental education (min - 1, max - 4, with higher score indicating higher educational degree). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07913425
GET https://conductscience.org/api/trials/v1/NCT07913425/registered